根据各种TIRADS的评估,甲状腺结节中FNAC指示的分析被认为是低风险的
European thyroid journal
|July 4, 2025
概括
在低风险甲状腺结节 (TIRADS 3) 中减少不必要的细针吸收细胞学 (UN-FNAC) 仍然具有挑战性. 所有甲状腺成像和报告数据系统 (TIRADS) 显示了UN-FNAC的高率,表明需要新的策略.
科学领域:
- 内分泌学 在内分泌学.
- 放射学 放射学是一门学科.
- 在瘤学瘤学.
背景情况:
- 甲状腺结节 (TN) 很常见,TIRADS 3病变对不必要的活检 (UN-FNAC) 构成挑战.
- 本研究分析了被归类为TIRADS 3的TN,以评估UN-FNAC的利率.
研究的目的:
- 在不同TIRADS分类系统中评估低风险甲状腺结节 (TIRADS 3) 中不必要的细针吸收细胞学 (UN-FNAC) 的速率.
- 为了比较ACR,EU和K-TIRADS在识别恶性结节和指导活检决策中的性能.
主要方法:
- 从2019年1月到2024年8月进行的甲状腺手术的回顾性审查.
- 使用ACR,EU和K-TIRADS进行手术前甲状腺超声波发现的分类.
- 组织学作为确定TIRADS 3结节的UN-FNAC速率的黄金标准.
主要成果:
- 分析了284个TIRADS 3结节,恶性瘤的风险高于预期 (ACR8.7%,EU10.7%,K10.1%).
- 比起ACR-TIRADS (46.7%),K-TIRADS表示活检的频率更高 (66.7%).
- 总体而言,联合国-FNAC的比例很高:95.3% (ACR),90.3% (EU) 和92.4% (K).
结论:
- 当前的TIRADS分类导致了低风险甲状腺结节不必要的活检的显著率.
- 虽然ACR-TIRADS可能会减少总活检,但UN-FNAC的比例仍然很高.
- 开发替代策略至关重要,以尽量减少不必要的程序.
相关概念视频
Synthesis and Regulation of Thyroid Hormones
5.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
5.1K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
127
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
127


